Anisole

Anisole

SCHEMBL2336801

COc1ccccc1.[F-].[H+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Anisole SCHEMBL14954316 0.94 CA4 (0.88)
Anisole SCHEMBL14954344 0.94 CA4 (0.88)
Anisole SCHEMBL30601749 0.94
Anisole SCHEMBL10721106 0.94 CA4 (1.00)
Anisole SCHEMBL1205 0.94
Anisole SCHEMBL28813915 0.94 CA4 (1.00)
Anisole SCHEMBL20328417 0.94
Anisole SCHEMBL8472521 0.94 CA4 (1.00)
Anisole SCHEMBL2493788 0.94 CA4 (1.00)
Anisole SCHEMBL27342302 0.94 CA4 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7692015-B2 Economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer LIANYUNGANG JINKANG PHARMACEUTICAL TECHNOLOGY CO. LTD. (CN) 2010-04-06 US claimed
EP-2121680-A1 A NOVEL AND ECONOMICAL PROCESS FOR PREPARING (S,S)-2, 8-DIAZABICYCLOÝ4.3.0¨NONANE AND ITS ENANTIOMER Wang, Zheqing (US) 2009-11-25 EP claimed
US-20080221329-A1 Novel and economical process for preparing (S, S)-2, 8-diazabicyclo[4.3.0]nonane and its enantiomer LIANYUNGANG JINKANG PHARMACEUTICAL TECHNOLOGY CO. LTD. (CN) 2008-09-11 US claimed
WO-2008085480-A1 A NOVEL AND ECONOMICAL PROCESS FOR PREPARING (S,S)-2, 8-DIAZABICYCLO[4.3.0]NONANE AND ITS ENANTIOMER WANG ZHEQING (US) 2008-07-17 WO claimed
US-7988972-B2 Monoclonal antibody for use in diagnosis, prevention and treatment of infectious mononucleosis and cell proliferative disorders ORTHO-CLINICAL DIAGNOSTICS, INC. (US) 2011-08-02 US disclosed
EP-0889052-B1 Immunoreactive peptides from Epstein-Barr virus ORTHO DIAGNOSTIC SYSTEMS INC (US) 2009-04-15 EP disclosed
EP-2013226-A2 PROCESSES FOR THE PREPARATION OF OCTREOTIDE Wockhardt Limited (IN) 2009-01-14 EP disclosed
US-20080175849-A1 IMMUNOREACTIVE PEPTIDES FROM EPSTEIN-BARR VIRUS ORTHO DIAGNOSTICS SYSTEMS, INC. (US) 2008-07-24 US disclosed
US-7326535-B2 Immunoreactive peptides from Epstein-Barr virus ORTHO DIAGNOSTIC SYSTEMS INC. (US) 2008-02-05 US disclosed
WO-2007110765-A2 PROCESSES FOR THE PREPARATION OF OCTREOTIDE WOCKHARDT LTD (IN) 2007-10-04 WO disclosed
US-7208469-B2 Therapeutic method AUCKLAND UNISERVICES LIMITED 2007-04-24 US disclosed
EP-1027027-B1 Use of amylin, adrenomedullin and analogues thereof for treating cartilage defects AUCKLAND UNISERVICES LTD (NZ) 2006-12-20 EP disclosed
EP-0395664-A1 RENIN INHIBITORS CONTAINING A (1-AMINO-2-HYDROXY-2-HETEROCYCLIC) ETHYL MOIETY THE UPJOHN COMPANY (US) 1990-11-07 EP disclosed
WO-1990010704-A1 A PROCESS FOR PRODUCING PENTAPEPTIDES AND INTERMEDIATES FOR USE IN THE SYNTHESIS CARLBIOTECH LTD. A/S (DK) 1990-09-20 WO disclosed
EP-0196174-B1 MEANS FOR SEQUENTIAL SOLID PHASE ORGANIC SYNTHESIS AND METHODS USING THE SAME SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) 1990-01-17 EP disclosed
WO-1989003842-A1 RENIN INHIBITORS CONTAINING A (1-AMINO-2-HYDROXY-2-HETEROCYCLIC) ETHYL MOIETY THE UPJOHN COMPANY (US) 1989-05-05 WO disclosed
EP-0233838-A2 Neurite-promoting factor and process for the manufacture thereof INCYTE PHARMACEUTICALS, INC. (US) 1987-08-26 EP disclosed
US-4631211-A REACTIVE PARTICLES ENCLOSED IN WATER AND SOLVENT-INSOLUBLE MESH CONTAINER; PEPTIDE SYNTHESIS SCRIPPS CLINIC & RESEARCH FOUNDATION (US) 1986-12-23 US disclosed
EP-0196174-A2 Means for sequential solid phase organic synthesis and methods using the same SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) 1986-10-01 EP disclosed
US-4128638-A Nona- and deca-peptide amide derivatives demonstrating high ovulation inducing activity ICI AUSTRALIA LIMITED (AU) 1978-12-05 US disclosed